Vitamin D is particularly important for women, playing a key role in bone health, immune function, and pregnancy. The standard test measures 25-hydroxyvitamin D in blood, with widely accepted but not universally standardized cutoffs: deficiency <20 ng/mL, insufficiency 20–30 ng/mL. The available studies (all cross-sectional or retrospective, 2025–2026) provide prevalence data but no interventional evidence. Genetic tests for vitamin D status, such as variants in VDR or GC genes, have limited predictive power and are not recommended in clinical practice. For women, especially during menopause or when planning pregnancy, optimizing vitamin D levels may be beneficial, but supplementation should be individualized and ideally guided by blood testing. The evidence is moderate: cutoffs are based on observational data, not randomized controlled trials. Therefore, results should be seen as guidance, not definitive medical advice. A home test can give an initial indication but does not replace professional consultation.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-cf51553ee56b15c8d9f4fdea